KELLY WALKER: Open Payments
NPI 1366992760 · ONEIDA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 54 payments from 16 companies in 2025. Trend: 2023 $1,033 · 2024 $1,024 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $212 |
| ABBVIE INC. | 14 | $175 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| Novo Nordisk Inc | 4 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
| Phathom Pharmaceuticals, Inc. | 3 | $33 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| UPSHER-SMITH LABORATORIES LLC | 1 | $31 |
| Averitas Pharma Inc. | 1 | $29 |
Products named: TRELEGY ELLIPTA, Kerendia, CAPLYTA, VRAYLAR, XIFAXAN, UBRELVY, Ozempic, QULIPTA.
Industry payments across TN — which companies pay providers there.
